Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
| Status: | Completed |
|---|---|
| Conditions: | High Cholesterol, Metabolic |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Pharmacology / Toxicology |
| Healthy: | No |
| Age Range: | 21 - 65 |
| Updated: | 4/17/2018 |
| Start Date: | July 2007 |
| End Date: | January 2009 |
Omacor: Measures of Endothelial Function and triGlyceride Alteration
The purpose of this study is to evaluate the cardiovascular and lipid effects of two doses of
an omega-3 fatty acid concentrate in a group of people who normally are not treated for high
lipids.
an omega-3 fatty acid concentrate in a group of people who normally are not treated for high
lipids.
Inclusion Criteria:
- triglycerides 150-500 mg/dL
- age 21-65 years
- generally healthy
- body mass index (BMI) 20-39 kg/m2
Exclusion Criteria:
- smoking
- premenopausal (if female)
- use of hormone replacement or oral contraceptives
- use of lipid lowering or blood pressure medication
- hypertension (blood pressure > 150/95 mm Hg)
- peripheral vascular disease
- heart disease, diabetes, or stroke
- inflammatory disease (e.g. rheumatoid arthritis or Crohn's)
- elevated liver enzymes
- high intake of omega-3 containing foods
- allergy to adhesive or latex
- use of aspirin, anticoagulants, or SSRI
We found this trial at
1
site
Click here to add this to my saved trials
